PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
news

New Gold Standard Guidelines for Psychedelic Trials

A new set of guidelines for the use of psychedelics in clinical trials including factors such as music, lighting, and cultural safety aims to become the "gold standa...
Continue Reading →
Regional News

Shifting Paradigms of Clinical Trial Design Accelerate CNS R&D

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been desig...
Continue Reading →
Regional News

Advancing Access to Clinical Trials for Cardiomyopathy

New American Heart Association initiative aims to improve education and outreach in clinical trials for progressive, often undiagnosed cardiomyopathy. Despite sci...
Continue Reading →
Regional News

Japan to Begin Clinical Trials for Artificial Blood This Year

Japan is the first country to begin clinical trials of artificial blood, a medical innovation which if proven successful, would solve one of the largest hospital cha...
Continue Reading →
Regional News

O’Shaughnessy says UK Clinical Trials Sector is on the Mend

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead," according to former healt...
Continue Reading →
Regional News

Otonomy’s Hearing Loss Drug Shows No Benefit in Trial, Tanking Shares

Otonomy has chalked up its second clinical trial failure in the space of a few months, the latest in a mid-stage study of a treatment for hearing loss, and the biote...
Continue Reading →
Regional News

GSK Promises to Publish Clinical Trial Data

Britain’s largest drugmaker GSK has announced its support for the AllTrials campaign, in a move to further demonstrate its commitment to clinical trial transparency....
Continue Reading →
Regional News

VistaGen’s Horizons May Shrink After Clinical Trial Setback

Shares in VistaGen Therapeutics have plummeted after the company reported that its lead pherine nasal spray candidate failed the first of two phase 3 trials in socia...
Continue Reading →
Regional News

Trials Set Up Filing for Lilly’s Tirzepatide in Sleep Apnoea

Eli Lilly’s diabetes and obesity therapy Tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 t...
Continue Reading →
Regional News

UK Company, Stablepharma Ltd, Enters Phase 1 Clinical Trials with World-First Fridge-Free Tetanus & Diphtheria Vaccine

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Pha...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026